Vertrix Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$237K Buy
1,503
+71
+5% +$11.2K 0.08% 92
2026
Q2
$227K Sell
1,432
-426
-23% -$57.6K 0.08% 97
2026
Q1
$237K Buy
+1,858
New +$232K 0.09% 92

Other funds holding XBI

Vertrix Wealth Management's XBI Position: Q3 2026 in Review

Vertrix Wealth Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 5% in Q3 2026, buying an estimated $11.2K and bringing the position to 1,503 shares worth $237K. The position accounts for 0.08% of the portfolio, ranked #92.

Vertrix Wealth Management first reported a position in XBI in Q1 2026 and has held it in 3 quarters since. The position peaked at $237K in Q1 2026. 963 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Vertrix Wealth Management held 1,503 shares of State Street SPDR S&P Biotech ETF worth $237K as of Q3 2026.
  • Vertrix Wealth Management bought 71 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $11.2K.
  • State Street SPDR S&P Biotech ETF made up 0.08% of Vertrix Wealth Management's portfolio in Q3 2026, its #92 holding.
  • Vertrix Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2026 and has held it in 3 quarters since.
  • Vertrix Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $237K in Q1 2026.
  • 963 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Vertrix Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.